Similar articles

• Ventricular Tachycardias: Characteristics and Management.

  Baldzizhar A, Manuylova E, Marchenko R, Kryvalap Y, Carey MG. Baldzizhar A, et al. Crit Care Nurs Clin North Am. 2016 Sep;28(3):317-29. doi: 10.1016/j.cnc.2016.04.004. Epub 2016 Jun 22. Crit Care Nurs Clin North Am. 2016. PMID: 27484660 Review.
• A case of a short-coupled variant of torsades de Pointes with electrical storm.

  Takeuchi T, Sato N, Kawamura Y, Takahashi F, Sato M, Kikuchi K, Akasaka N, Go K, Fujimoto K, Hasebe N. Takeuchi T, et al. Pacing Clin Electrophysiol. 2003 Feb;26(2 Pt 1):632-6. doi: 10.1046/j.1460-9592.2003.00106.x. Pacing Clin Electrophysiol. 2003. PMID: 12710326
• Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias.

  Hoehns JD, Stanford RH, Geraets DR, Skelly KS, Lee HC, Gaul BL. Hoehns JD, et al. Pharmacotherapy. 2001 Jul;21(7):871-83. doi: 10.1592/phco.21.9.871.34565. Pharmacotherapy. 2001. PMID: 11444585 Review.
• A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).

  Lu HR, Yan GX, Gallacher DJ. Lu HR, et al. J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):250-259. doi: 10.1016/j.vascn.2013.01.003. Epub 2013 Jan 19. J Pharmacol Toxicol Methods. 2013. PMID: 23337247
• Self-Terminating Ventricular Fibrillation in Vandetanib-Induced Torsades de Pointes.

  Loffi M, Toffetti L, Gianni C, Lombardi F. Loffi M, et al. J Cardiovasc Electrophysiol. 2015 Jul;26(7):811-3. doi: 10.1111/jce.12628. Epub 2015 Mar 19. J Cardiovasc Electrophysiol. 2015. PMID: 25648339 No abstract available.